BIOMAT Database Logo BIOMAT Database Logo

[Somatostatin analogues in the treatment of paraneoplastic hypercorticism]. 1992

Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic

UI MeSH Term Description Entries
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D010257 Paraneoplastic Syndromes In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. Paraneoplastic Syndrome,Syndrome, Paraneoplastic,Syndromes, Paraneoplastic
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000308 Adrenocortical Hyperfunction Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM. Hyperadrenocorticism,Hypercorticism,Adrenal Gland Hyperfunction,Hyperadrenalism,Hyperfunction, Adrenal Gland,Hyperfunction, Adrenocortical
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015282 Octreotide A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula. Octreotide Acetate,Compound 201-995,Octreotide Acetate Salt,SAN 201-995,SM 201-995,SMS 201-995,Sandostatin,Sandostatine,Sandoz 201-995,Compound 201 995,Compound 201995,SAN 201 995,SAN 201995,SM 201 995,SM 201995,SMS 201 995,SMS 201995,Sandoz 201 995,Sandoz 201995
D015408 Gastrinoma A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1). Gastrin-Producing Tumor,Islet Cell Tumor, Ulcerogenic,Ulcerogenic Islet Cell Tumor,Gastrin Producing Tumor,Gastrin-Producing Tumors,Gastrinomas,Tumor, Gastrin-Producing,Tumors, Gastrin-Producing

Related Publications

Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Paraneoplastic hypercorticism].
January 1984, Annales de medecine interne,
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Paraneoplastic hypercorticism].
January 1966, L'Annee endocrinologique,
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Paraneoplastic hypercorticism syndrome].
November 1969, Giornale di clinica medica,
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Syndromes of paraneoplastic adrenal hypercorticism].
January 1961, La Presse medicale,
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
Epithelioid haemangioendothelioma and paraneoplastic hypercorticism.
November 2004, Rheumatology (Oxford, England),
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Paraneoplastic hypercorticism. Apropos of 5 cases].
January 1972, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Somatostatin analogues in the treatment of carcinoid].
January 2008, Casopis lekaru ceskych,
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Paraneoplastic hypercorticism associated with a bronchial adenocarcinoma].
June 1999, Revue des maladies respiratoires,
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Paraneoplastic hypercorticism. Clinical, biochemical and morphological findings].
May 1966, Deutsche medizinische Wochenschrift (1946),
Y Lorcy, and N Le Moullec, and A M Le Guerrier, and H Allannic
[Paraneoplastic hypercorticism. Report on an oligosymptomatic observation].
May 1972, Das Deutsche Gesundheitswesen,
Copied contents to your clipboard!